other_material
confidence high
sentiment neutral
materiality 0.55
Biofrontera stockholders approve reverse stock split and preferred stock conversion proposals
Biofrontera Inc.
- Reverse stock split amendment approved (7,161,214 for, 1,239,537 against) to maintain Nasdaq minimum bid price compliance.
- Issuance of common stock upon conversion of Series C Preferred Stock and elimination of voting limits approved (3,470,432 for).
- Issuance of common stock upon conversion of Series D Preferred Stock and elimination of voting limits approved (5,053,120 for).
- Adjournment proposal approved (7,371,647 for) to allow further solicitation if needed for other proposals.
item 5.07